CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Likewise, CD34+CD38−ALDHhigh cells show enrichment for CML LSCs with enhanced engraftment capabilities in immune deficient mice compared to the remaining CD34+CD38− cells[20].